Industrial Alliance Investment Management Inc. Bristol Myers Squibb CO Transaction History

Industrial Alliance Investment Management Inc.

$196 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $7,676 - $8,704	160 New	160 $9,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $21.8 Million - $24.2 Million	-342,172 Reduced 98.56%	5,000 $320,000
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $6.28 Million - $7.12 Million	-95,539 Reduced 21.58%	347,172 $24.1 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $3.67 Million - $4.34 Million	-53,529 Reduced 10.79%	442,711 $31.9 Million
Q3 2022 Nov 18, 2022	SELL	$0.13 - $76.84 $2,705 - $1.6 Million	-20,811 Reduced 4.02%	496,240 $35.3 Million
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $4.66 Million - $5.13 Million	-64,194 Reduced 11.04%	517,051 $39.8 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $2 Million - $2.4 Million	-32,610 Reduced 5.31%	581,245 $42.4 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $30.9 Million - $36 Million	575,581 Added 1503.84%	613,855 $38.3 Million
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $2.05 Million - $2.39 Million	38,274 New	38,274 $614 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.7 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.01 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.28 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.43 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.47 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Industrial Alliance Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Industrial Alliance Investment Management Inc. with notifications on news.

Account